摘要
肺再移植是初次肺移植后慢性肺移植物失功(CLAD)的最终治疗手段。近年来,肺再移植手术量逐年升高,肺再移植患者的预后不断改善。但在世界范围内肺再移植开展总量和所占比重均较小,与初次肺移植患者相比,肺再移植患者术后生存时间仍有较大差距。该文通过透视国际心肺移植协会(ISHLT)统计数据,对肺再移植治疗的发展现状进行综述。
Lung re transplantation is the ultimate treatment of chronic lung allograft dysfunction(CLAD)after initial lung transplantation.The total number and proportion of lung re transplantation are relatively small around the world,but it has become more frequent in recent years.Survival after lung re transplantation has improved over time,but still lags behind that of initial lung transplantation.This review focused on the topic of lung re transplantation and incorporated several new related analyses from the International Society for Heart and Lung Transplantation(ISHLT).
作者
周文勇
曹克坚
Zhou Wenyong;Cao Kejian(Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai200030, China)
出处
《中华胸部外科电子杂志》
2017年第4期244-248,共5页
CHINESE JOURNAL OF THORACIC SURGERY：Electronic Edition
基金
国家自然基金项目(81700092)
中国博士后科学基金面上项目(2016M601603)
上海市卫计委局青课题(20174Y0234)
关键词
肺再移植
预后
慢性肺移植物失功
国际心肺移植协会
Lung re transplantation
Prognosis
Chronic lung allograft dysfunction
International Society for Heart and Lung Transplantation
